Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Novabay Pharmaceuticals (NBY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,397
  • Shares Outstanding, K 15,370
  • Annual Sales, $ 11,900 K
  • Annual Income, $ -13,150 K
  • 36-Month Beta -0.69
  • Price/Sales 5.91
  • Price/Cash Flow 0.00
  • Price/Book 38.27

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.15 +4.82%
on 11/15/17
4.80 -9.38%
on 10/27/17
+0.05 (+1.16%)
since 10/20/17
3-Month
4.00 +8.75%
on 09/15/17
4.80 -9.38%
on 10/27/17
-0.35 (-7.45%)
since 08/22/17
52-Week
2.25 +93.33%
on 06/02/17
5.00 -13.00%
on 08/07/17
+0.10 (+2.35%)
since 11/22/16

Most Recent Stories

More News
NovaBay Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 14, 2017 / NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) will be discussing their earnings results in their Q3 Earnings Call to be held on Tuesday, November 14,...

NBY : 4.35 (-2.25%)
Eye Surgeon Says Keep Eyelids Healthy with Avenova from NovaBay

COLUMBUS, OH / ACCESSWIRE / September 18, 2017 / Alice T. Epitropoulos, MD, FACS, co-founder of The Eye Center of Columbus and eye surgeon at the Cataract & Refraction Center of Ohio, offers women advice...

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals to Present at Rodman & Renshaw 19th Annual Global Investment Conference

NovaBay(R) Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova(R) lid and lash hygiene for the domestic eye care ...

NBY : 4.35 (-2.25%)
NovaBay's Avenova Offers Key Benefits in Glaucoma Care

Daily Wipes with Avenova for Eyelid Hygiene can Prevent some of the Worrisome Complications of Glaucoma, Reports a Top Ophthalmologist

NBY : 4.35 (-2.25%)
NovaBay's Avenova Highlighted in National Dry Eye Awareness Month

Daily Wipes with a New Eyelid Hygiene Product Can Finally Bring Relief from an Often-Painful Condition, Reports a Top Eye Doctor

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals Announces CFO Transition

NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a specialty pharmaceutical company focusing on commercializing prescription Avenova(R) for lid and lash hygiene in the domestic eye...

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals Joins the Russell Microcap Index

NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on commercializing prescription Avenova(R) lid and lash hygiene for the domestic eye care market,...

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals to Present at the 7th Annual LD Micro Invitational

NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova(R) lid and lash hygiene for the domestic eye care market,...

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE MKT

NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY) today announced receipt of a letter from NYSE MKT LLC ("NYSE MKT" or the "Exchange") on May 16, 2017, stating that it is not in compliance...

NBY : 4.35 (-2.25%)
NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results

--Conference call begins today at 4:30 p.m. Eastern time

NBY : 4.35 (-2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds,...

See More

Key Turning Points

2nd Resistance Point 4.60
1st Resistance Point 4.47
Last Price 4.35
1st Support Level 4.29
2nd Support Level 4.23

See More

52-Week High 5.00
Last Price 4.35
Fibonacci 61.8% 3.95
Fibonacci 50% 3.63
Fibonacci 38.2% 3.30
52-Week Low 2.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart